Company Alfresa Holdings Corporation
Stocks
2784
JP3126340003
Medical Equipment, Supplies & Distribution
|
Market Closed -
Japan Exchange
02:30:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 2,415.00 JPY | -1.75% |
|
+2.85% | -0.66% |
| 10-05 | Healios Completes First 144 Million Yen Culture Supernatant Shipment to JENECEL | MT |
| 06-30 | Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation | CI |
Business description: Alfresa Holdings Corporation
Number of employees: 12,525
Sales by Activity: Alfresa Holdings Corporation
| Fiscal Period: March | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) | 2026 (JPY) |
|---|---|---|---|---|---|
Pharmaceutical Products Wholesale Segment | 2,288B | 2,395B | 2,540B | 2,640B | 2,783B |
Self-Medication Wholesale Business | 245B | 247B | 263B | 266B | 267B |
Pharmaceutical Manufacturing Business | 47.36B | 49.04B | 52.74B | 54.06B | 52.18B |
Dispensing Pharmacy Business | 34.47B | 36.2B | 36.65B | 37.02B | 37.17B |
Unallocated Adjustment | -29.11B | -31.21B | -33.67B | -35.83B | -34.95B |
Geographical breakdown of sales: Alfresa Holdings Corporation
| Fiscal Period: March | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) | 2026 (JPY) |
|---|---|---|---|---|---|
Japan | 2,586B | 2,696B | 2,858B | 2,961B | 3,104B |
Executive Committee: Alfresa Holdings Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Ryuji Arakawa
CEO | Chief Executive Officer | 63 | - |
Watase Maiko
ADM | Chief Administrative Officer | - | - |
Toshiki Tanaka
CTO | Chief Tech/Sci/R&D Officer | 63 | 2022-06-27 |
Shigeki Ohashi
PRN | Corporate Officer/Principal | 61 | 2020-03-31 |
Yusuke Fukujin
PRN | Corporate Officer/Principal | 50 | 2022-03-31 |
Composition of the Board of Directors: Alfresa Holdings Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Yusuke Fukujin
BRD | Director/Board Member | 50 | 2020-05-31 |
Ryuji Arakawa
BRD | Director/Board Member | 63 | 2007-05-31 |
Manabu Kinoshita
BRD | Director/Board Member | 72 | 2020-05-31 |
Kimiko Kunimasa
BRD | Director/Board Member | 66 | 2022-05-31 |
Hiroshi Kizaki
BRD | Director/Board Member | 67 | - |
Yuji Ueda
BRD | Director/Board Member | 65 | 2025-06-24 |
Koichi Shimada
BRD | Director/Board Member | 68 | 2018-05-31 |
Shigeki Ohashi
BRD | Director/Board Member | 61 | 2022-05-31 |
Toshiki Tanaka
BRD | Director/Board Member | 63 | 2022-06-27 |
Toshie Takeuchi
BRD | Director/Board Member | 71 | 2020-05-31 |
Holdings: Alfresa Holdings Corporation
| Name | Stocks | % | Valuation |
|---|---|---|---|
| 15,405,703 | 8.05% | 223 M $ | |
| 2,072,000 | 0.38% | 153 M $ | |
MATSUKIYOCOCOKARA & CO. 0.54% | 2,189,766 | 0.54% | 34 M $ |
| 1,260,000 | 1.32% | 30 M $ | |
| 1,912,865 | 0.38% | 29 M $ | |
INNOVACELL INC. 3.1% | 1,398,671 | 3.1% | 6 M $ |
TSUMURA & CO. 0.3% | 228,100 | 0.3% | 5 M $ |
| 229,400 | 0.1% | 4 M $ | |
| 182,412 | 0.5% | 4 M $ | |
| 152,767 | 0.33% | 4 M $ |
Company details: Alfresa Holdings Corporation
Other Medical Equipment, Supplies & Distribution
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.75% | +2.85% | +8.98% | +1.32% | 2.73B | |
| +0.12% | +2.70% | -18.47% | +10.99% | 178B | |
| +0.42% | +1.71% | -19.49% | +15.27% | 116B | |
| +1.01% | +2.23% | +2.01% | +35.92% | 115B | |
| -2.17% | +2.33% | -43.98% | +5.69% | 93.1B | |
| +0.25% | -4.14% | -2.77% | +76.00% | 62.09B | |
| +0.17% | +1.64% | +8.50% | +82.24% | 55.87B | |
| +0.05% | +0.52% | +6.05% | -22.20% | 53.12B | |
| +0.69% | +1.61% | -11.34% | +41.88% | 44.22B | |
| +0.33% | +3.47% | -2.69% | -8.39% | 33.59B | |
| Average | -0.08% | +2.51% | -7.32% | +23.87% | 75.37B | |
| Weighted average by Cap. | +0.07% | +2.38% | -12.41% | +24.01% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2784 Stock
- Company Alfresa Holdings Corporation
Select your edition
All financial news and data tailored to specific country editions
